Company intelligence / Profile preview

ZKB Pharma Vision Fund

Zurich, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

ZKB Pharma Vision Fund is a specialized investment vehicle managed by Zürcher Kantonalbank (ZKB) that focuses on the global pharmaceutical, biotechnology, and healthcare sectors. Based in Zurich, Switzerland, the fund invests in both public equities and private venture-stage companies, particularly those within the Swiss life sciences ecosystem. It is part of ZKB's broader asset management offering under the Swisscanto brand. The fund aims to identify and support innovative companies developing transformative medical technologies and therapeutic approaches. It has historically been a significant investor in the Swiss biotech ecosystem, supporting companies such as PharmaBiome and Auris Medical.

Industry: Investors

Beyond the preview

Go deeper on ZKB Pharma Vision Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZKB Pharma Vision Fund.

Explore the full profile